TotalMarketCap

Emergent BioSolutions

EBSNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$300.008 M

$5.84 -1.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Emergent BioSolutions (EBS) has a market capitalization of $300.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$742.9M

#1686 by revenue

Earnings

$52.6M

#1536 by earnings

Shares outstanding

51,415,182

Latest filing cover page

P/E ratio

5.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #217Benitec BiopharmaBNTC$303.2M
  2. #218Galectin TherapeuticsGALT$301.2M
  3. #219Emergent BioSolutionsEBS$300.0M
  4. #220Enanta PharmaceuticalsENTA$294.2M
  5. #221Prelude TherapeuticsPRLD$283.7M

What if Emergent BioSolutions were worth as much as…

Open the what-if tool →

Gold $28.2T

$549,193.31

Per share 94,121× higher

Bitcoin $1.53T

$29,715.89

Per share 5,093× higher

Apple $5.02T

$97,554.50

Per share 16,719× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Emergent BioSolutions are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.